Loading…
Cody Miller Patient Medication Information Act
Legislative Progress
Introduced
October 28, 2015
Latest Action
October 28, 2015
Primary Sponsor
Kirsten E. GillibrandDemocratic(NY)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,548 other S bills in the 114th — cohort avg 43d
Cody Miller Patient Medication Information Act This bill amends the Federal Food, Drug, and Cosmetic Act to direct the Food and Drug Administration (FDA) to regulate the authorship, content, format, and dissemination of patient medication information for prescription drugs. (Patient medication information includes the instructional brochures provided to patients when a prescription is filled.) FDA regulations must require drug patient medication information to be scientifically accurate, to be based on the approved professional labeling, and to include plain language that is not promotional in tone or content and that provides specified information including drug uses and side effects. The regulations must include standards for: (1) timely reviews and updates of patient medication information, (2) updates to help communicate information that is shared by similar drugs, and (3) assessing the effectiveness of patient medication information in promoting patient understanding and safe and effective use of medications. The FDA must develop a public electronic repository for all patient medication information. When a prescription drug is sold or dispensed, patient medication information must be provided.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2017 · first_quarter · Health Issues
Issues related to SEC proposed rule 30e-3 and the FY 2017 Financial Services and General Government appropriations legislation S. 2214, The Cody Miller Patient Medical Information Act, regarding all provisions.
Client expense: Not reported · Firm income: $70,000
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Health Issues
Issues related to SEC proposed rule 30e-3 and the FY 2017 Financial Services and General Government appropriations legislation S. 2214, The Cody Miller Patient Medical Information Act, regarding all provisions.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
Issues related to SEC proposed rule 30e-3 and the FY 2017 Financial Services and General Government appropriations legislation S. 2214, The Cody Miller Patient Medical Information Act, regarding all provisions.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Pharmacy
Reimbursement of Pharmacist Services (HR592, S314) Transitions of Care Risk Evaluation and Mitigation Services Track and Trace/Supply Chain Health Information Technology Immunizations Compounding Tele-medicine Quality Rating AMP FULs/MAC Pricing Biosimiliars/Biologic Products (S 2700) Drug Importation Generics Labeling Pharmacy Benefit Managers Preferred Pharmacy Network (HR793) Electronic Labeling 21st Century Cures (HR6, HR 350) Drug Disposal/Management Drug Prices Direct and Indirect Remuneration Fees (HR 5951, S 3308) Cody Miller Act (S 2214) Lab Developed Tests
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2016 · second_quarter · Health Issues
Issues related to SEC proposed rule 30e-3 and the FY 2017 Financial Services and General Government appropriations legislation S. 2214, The Cody Miller Patient Medical Information Act, regarding all provisions.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| OH |